AzTrials
AzTrials

Total Knee Arthroplasty (TKA)NCT05310474

Does an Active Range of Motion Monitor Improve Outcomes/Decrease Cost for Patients Undergoing Total Knee Arthroplasty?

A study testing Knee Glider in people with Total Knee Arthroplasty (TKA), run by Force Therapeutics.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Total Knee Arthroplasty (TKA)
What is being tested?
Knee Glider
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
30 Apr 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals who have undergone Total Knee Arthroplasty (TKA) and have agreed to participate in this study.

Who cannot join

  • Individuals who have not undergone TKA.

Trial locations and contacts

No sites are listed yet.

Ben Koerner, DO, MBA contact

(316)648-5158

benkoerner5@gmail.com

About this study

Official title: Does an Active Range of Motion Monitor Improve Outcomes and Decrease Cost for Patients Undergoing Total Knee Arthroplasty?

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA.

Read the detailed description

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA. Patients will be given the opportunity to participate, and enrolled and consented participants will be treated and followed by physicians from OSI Orthopedic \& Sports Medicine. Upon consent, patients will be randomized to receive the active range of motion monitor (the knee glider) two weeks prior to surgery, near day of surgery to use postoperatively, or standard of care (no knee glider). All patients enrolled in the study will have access to Force Therapeutics, patient engagement and outcome collection system utilized by OSI Orthopedic \& Sports Medicine. Enrolled subjects will be followed from the time of consent, through 6 months following surgery. Patients who are randomized into groups receiving the knee glider will receive the knee glider for up to 4 weeks following surgery, and compliance will be monitored. The hypothesis of this study is that patients who utilize an active range of motion monitor (the knee glider) will have improved clinical outcomes over patients receiving standard of care.

Being tested
Knee Glider

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Knee GliderDevice

    The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA.

Study groups in NCT05310474
Study groupRoleWhat they receive
Group CNo interventionUpon consent, patients will be randomized to receive standard of care, and not be given the active range of motion monitor (the knee glider) two weeks prior to surgery. All patients enrolled in the study will have access to Force Therapeutics, patient engagement and outcome collection system utilized by OSI Orthopedic \& Sports Medicine.
Group BExperimentalUpon consent, patients will be randomized to receive the active range of motion monitor (the knee glider) close to surgery to use postoperatively (through week 4). All patients enrolled in the study will have access to Force Therapeutics, patient engagement and outcome collection system utilized by OSI Orthopedic \& Sports Medicine.
Receives: Device: Knee Glider
Group AExperimentalUpon consent, patients will be randomized to receive the active range of motion monitor (the knee glider) Receives Knee Glider 2 weeks prior to surgery to utilize through postoperative week 4. All patients enrolled in the study will have access to Force Therapeutics, patient engagement and outcome collection system utilized by OSI Orthopedic \& Sports Medicine.
Receives: Device: Knee Glider

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baseline Patient Characteristics

    Intended to collect patient demographics, contact information, birth date, surgery date, age and other baseline demographic variables.

    Measured: Baseline

  2. Knee Injury and Osteoarthritis Outcome Score (KOOS Jr.)

    Intended to elicit people's opinions about the difficulties they experience due to problems with their knee and covers aspects of pain, functional limitations and knee-related quality of life.

    KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

    Measured: Baseline, 2 Weeks Post Op, 6 Weeks Post Op, 12 Weeks Post Op, 6 Months Post Op,

  3. Knee Injury and Osteoarthritis Outcome Score (KOOS Jr.)

    Intended to elicit people's opinions about the difficulties they experience due to problems with their knee and covers aspects of pain, functional limitations and knee-related quality of life.

    KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

    Measured: 6 Weeks Post Op

  4. Knee Injury and Osteoarthritis Outcome Score (KOOS Jr.)

    Intended to elicit people's opinions about the difficulties they experience due to problems with their knee and covers aspects of pain, functional limitations and knee-related quality of life.

    KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

    Measured: 12 Weeks Post Op

  5. Knee Injury and Osteoarthritis Outcome Score (KOOS Jr.)

    Intended to elicit people's opinions about the difficulties they experience due to problems with their knee and covers aspects of pain, functional limitations and knee-related quality of life.

    KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

    Measured: 6 Months Post Op

  6. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    1. The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness in the past 48 hours.
    2. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).
    3. Scores can be calculated for each subscale and a total score is calculated by adding all 3 subscale scores. Higher points signify higher levels of functional difficulty.

    Measured: Baseline

  7. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    1. The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness in the past 48 hours.
    2. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).
    3. Scores can be calculated for each subscale and a total score is calculated by adding all 3 subscale scores. Higher points signify higher levels of functional difficulty.

    Measured: 6 Weeks Post Op

  8. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    1. The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness in the past 48 hours.
    2. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).
    3. Scores can be calculated for each subscale and a total score is calculated by adding all 3 subscale scores. Higher points signify higher levels of functional difficulty.

    Measured: 12 Weeks Post Op

  9. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    1. The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness in the past 48 hours.
    2. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items).
    3. Scores can be calculated for each subscale and a total score is calculated by adding all 3 subscale scores. Higher points signify higher levels of functional difficulty.

    Measured: 6 Months Post Op

  10. Veterans RAND 12 (VR-12)

    1. The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.

    Measured: Baseline

  11. Veterans RAND 12 (VR-12)

    The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.

    Measured: 6 Weeks Post Op

  12. Veterans RAND 12 (VR-12)

    The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.

    Measured: 12 Weeks Post Op

  13. Veterans RAND 12 (VR-12)

    The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.

    Measured: 6 Months Post Op

  14. Force Patient Engagement

    Engagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access

    Measured: Baseline

  15. Force Patient Engagement

    Engagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access

    Measured: 2 Weeks Post Op

  16. Force Patient Engagement

    Engagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access

    Measured: 6 Weeks Post Op

  17. Force Patient Engagement

    Engagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access

    Measured: 12 Weeks Post Op

  18. Force Patient Engagement

    Engagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access

    Measured: 6 Months Post Op

  19. Range of Motion via the Knee Glider

    Daily Knee Flexion and Extension for the duration of utilizing the knee glider

    Measured: Baseline

  20. Range of Motion via the Knee Glider

    Daily Knee Flexion and Extension for the duration of utilizing the knee glider

    Measured: 2 Weeks Post Op

  21. Range of Motion via the Knee Glider

    Daily Knee Flexion and Extension for the duration of utilizing the knee glider

    Measured: 6 Weeks Post Op

  22. Range of Motion via the Knee Glider

    Daily Knee Flexion and Extension for the duration of utilizing the knee glider

    Measured: 12 Weeks Post Op

  23. Range of Motion (Exam / Patient Reported)

    1. Knee Flexion and Extension via in clinic exam or patient reported via the Force Therapeutics Platform

    Measured: Baseline

  24. Range of Motion (Exam / Patient Reported)

    1. Knee Flexion and Extension via in clinic exam or patient reported via the Force Therapeutics Platform (0 to 110 degrees)

    Measured: 2 Weeks Post Op

  25. Range of Motion (Exam / Patient Reported)

    1. Knee Flexion and Extension via in clinic exam or patient reported via the Force Therapeutics Platform (0 to 110 degrees)

    Measured: 6 Weeks Post Op

  26. Range of Motion (Exam / Patient Reported)

    1. Knee Flexion and Extension via in clinic exam or patient reported via the Force Therapeutics Platform (0 to 110 degrees)

    Measured: 12 Weeks Post Op

  27. Daily NRS Pain (Continuous)

    The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain

    Measured: Baseline

  28. Daily NRS Pain (Continuous)

    The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain

    Measured: 2 Weeks

  29. Daily NRS Pain (Continuous)

    The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain

    Measured: 6 Weeks

  30. Daily NRS Pain (Continuous)

    The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain

    Measured: 12 Weeks

  31. Discharge Services Utilization & Cost

    The Discharge Services Utilization \& Cost survey is intended collect patient discharge information. The survey consists of 16 questions asking about where they went for physical therapy, how much it costs, and if any adverse events resulted in admission to an Emergency Room or Urgent Care.

    Measured: 6 Weeks Post Op

  32. Discharge Services Utilization & Cost

    The Discharge Services Utilization \& Cost survey is intended collect patient discharge information. The survey consists of 16 questions asking about where they went for physical therapy, how much it costs, and if any adverse events resulted in admission to an Emergency Room or Urgent Care.

    Measured: 12 Weeks Post Op

  33. Knee Glider Satisfaction

    The Knee Glider Satisfaction questionnaire is a 4 question survey asking about patient experience using the glider.

    Measured: 2 Weeks Post Op

  34. Knee Glider Satisfaction

    The Knee Glider Satisfaction questionnaire is a 4 question survey asking about patient experience using the glider.

    Measured: 6 Weeks Post Op

  35. Knee Glider Satisfaction

    The Knee Glider Satisfaction questionnaire is a 4 question survey asking about patient experience using the glider.

    Measured: 12 Weeks Post Op

  36. Total Joint Replacement (TJR) Satisfaction

    The TJR Satisfaction survey intends to understand patient experience and satisfaction results with their total joint replacement procedure.

    Measured: 12 Weeks Post Op

  37. Total Joint Replacement (TJR) Satisfaction

    The TJR Satisfaction survey intends to understand patient experience and satisfaction results with their total joint replacement procedure.

    Measured: 6 Months Post Op

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2022
  2. Study start30 Apr 2022 (estimated)
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study includes 3 arms.
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05310474
Sponsor's protocol ID
Rehab360 Knee Glider
Status last verified
Apr 2022
First submitted
14 Dec 2021
Last updated
14 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Knee Glider in people with Total Knee Arthroplasty (TKA), run by Force Therapeutics.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Joyce Harary, BA (6463319165, joyce@forcetherapeutics.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baseline Patient Characteristics (time frame: Baseline). The study lists 37 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in